The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.Based on available information, the cause of the reported entrapment of device (clip caught on chordae) appears to be due to the user technique.The reported incomplete coaptation is a cascading effect of the reported entrapment of device (clip caught on chordae).The reported tissue injury, mr is a cascading effect of the reported incomplete coaptation.The reported cardiogenic shock was a cascading effect of the reported mr.Additionally, the reported patient effects of tissue injury and mitral regurgitation are listed in the instructions for use, and are known possible complications associated with mitraclip procedures.The reported hospitalization and medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 3-4.A mitraclip xtw was implanted without issues reducing mr to <1.On (b)(6)2023, the patient experienced cardiogenic shock.An echocardiogram was performed which revealed recurrent mitral regurgitation (mr) grade 4, a leaflet tear, and that the clip had detached from the posterior mitral leaflet (pml) resulting in a single leaflet device attachment (slda).Imaging suggested there was chordal entrapment on the anterior leaflet.To stabilize the slda, two mitraclip xt devices were implanted.The mr was reduced to grade 1.Within twelve hours post procedure, the cardiogenic shock resolved.No additional information was provided.
|